1.New Theraputic Strategies of Acute Coronary Syndrome.
Journal of the Korean Academy of Family Medicine 2004;25(1):1-10
No abstract available.
Acute Coronary Syndrome*
2.Acute Coronary Syndrome.
Korean Circulation Journal 1998;28(12):2066-2066
No abstract available.
Acute Coronary Syndrome*
3.Research update on Kounis syndrome.
Chinese Journal of Cardiology 2013;41(6):527-529
6.Apolipoprotein levels in patients with Acute Coronary Syndrome (LIPAS): A pilot study
Elleen L. Cunanan ; John Daniel A. Ramos ; Mariel I. Barcelon-Cruz ; Elmer Jasper B. Llanes ; Felix Eduardo R. Punzalan ; Paul Ferdinand M. Reganit ; Lourdes Ella G. Santos ; Rody G. Sy ; Jezreel L. Taquiso
Philippine Journal of Internal Medicine 2018;56(2):56-61
Introduction:
Lowering levels of low-density lipoprotein cholesterol (LDL-C) are proven to reduce cardiovascular risk. However, some individuals experience acute coronary events despite normal LDL-C levels. Recent studies have focused on modifiable lipoprotein targets, such as apolipoprotein B (apo-B) and apolipoprotein A-1 (apo A-1) and lipoprotein (a), as targets for therapy. Apo-B is the primary apolipoprotein of LDL-C representing total number of atherogenic particles. Apolipoprotein A-1 is the major component of HDL complex. This study will determine the prevalence of elevated apo-B and low apo A-1 among adult Filipinos with acute coronary syndrome (ACS).
Methods:
This is a cross-sectional study involving 95 patients with ACS admitted in a tertiary hospital from November 2015 to May 2016. Levels of apo-B, apoA-1, lipoprotein (a), total cholesterol, triglyceride, LDL-C, and high-density lipoprotein cholesterol (HDL-C) were measured within 24 hours upon admission.
Results:
Forty-eight (48%) percent of patients was diagnosed with Non ST-Elevation-ACS, 39% with ST-Elevation myocardial infarction (STEMI) and 13% with unstable angina.Thirtytwo (32%) percent were on low- to high-intensity statin treatment. The mean LDL-C, non-HDL-C, and HDL-C levels were 109 mg/dL, 135 mg/dL, and 36.89 mg/dL, respectively. The prevalence of elevated apo-B (mean=103.79 mg/ dL; target:<80 mg/dL) was 82%, while that of low apo A-1 (mean=119 mg/dL; target: >120 mg/dL for males, >140 mg/dL for females) was 63%. Lipoprotein (a) levels are high (mean = 48.51 nmol/L; normal:<35 nmol/L) in 42% of patients. Among those on statin therapy, the mean LDL-C was 85 mg/dl, but the mean apo B and lipoprotein (a) levels were elevated at 87.57 mg/dL and 41 nmol/L, respectively.
Conclusion
Elevated levels of apo B and lipoprotein (a) and low level of apo A-1 are highly prevalent in patients with ACS. Apo-B and lipoprotein (a) levels are likewise elevated among patients with normal LDL levels.
Acute Coronary Syndrome
;
Apolipoproteins
7.The acute coronary syndrome risk in medically managed subjects with type 2 diabetes mellitus – Is the ASCVD risk score failing here?
Ameya Joshi ; Harminder Singh ; Sanjay Kalra
Journal of the ASEAN Federation of Endocrine Societies 2024;39(1):31-36
Objectives:
Type 2 Diabetics have elevated risk for acute coronary syndrome (ACS). The current management algorithm focuses on atherosclerotic cardiovascular (ASCVD) risk score to stratify this risk. However, in medically managed subjects, this algorithm may not be accurate. This study compares the ASCVD risk score in an Indian population with T2DM under medical supervision and the actual incidence of ACS. It also compared the ASCVD risk scores in cases with T2DM who developed ACS to controls and tried to estimate whether the ASCVD risk score is different in the two subsets, evaluating the utility of the ASCVD risk score in predicting ACS.
Methodology:
This is an electronic medical record (EMR) based case-control study. Only records of subjects with T2DM where details of age, sex, body mass index, blood pressure, duration of diabetes, family history of ACS, lipid profile, renal and liver function tests were included. The incidence of ACS was calculated in the selected records, and the records of subjects with ACS were compared with age and sex-matched subjects without ACS. Data are summarized as median and interquartile range (IQR). Wilcoxon rank-sum test was used for checking differences in continuous variables and Pearson’s Chi-squared test for categorical data. Univariate and multivariate logistic regression analyses were used to check the effect of ASCVD scores and other variables on the occurrence of ACS. Statistical data analyses were performed using JASP, version 0.16.4 (JASP Team [2022]) for MS Windows.
Results:
Of the 1226 EMRs included in the analysis, 207 had ACS. The actual incidence of ACS was 16.85% in 6 years, higher than the mean predicted 10-year incidence of 14.56 percent (p <0.05). The cases were age and sex-matched with controls and the ASCVD incidence was estimated in the two groups. The mean ASCVD score in the cases was 14.565 ± 8.709 (Min: 1.5, Max: 38.3) and controls 13.114 ± 8.247 (Min: 1.4, Max: 45). The chance of development of ACS increases with elevated systolic blood pressure (per mmHg rise OR: 1.04, 95% CI: 1.03, 1.06; p <0.001), positive family history (OR: 5.70, 95% CI: 3.41, 9.77; p <0.001), statin use (OR: 2.26, 95% CI: 1.46, 3.52; p <0.001), and longer duration of diabetes (for every year increase OR: 1.19, 95% CI: 1.13, 1.25; p <0.001)
Conclusion
The ASCVD risk score underestimates the ACS risk in subjects with T2DM under medical supervision and may not differ in those who developed and did not develop ACS. We also conclude that factors like a negative family history (30% less risk), longer duration of diabetes, and higher SBP are relevant in those who developed ACS.
Acute Coronary Syndrome
9.Is Dalteparin Safe in Patients with Acute Coronary Syndrome?.
Korean Circulation Journal 2003;33(8):653-655
No abstract available.
Acute Coronary Syndrome*
;
Dalteparin*
;
Humans
10.The first results of primary PCI in ACS patients at Hue Central Hospital
Journal of Vietnamese Medicine 2005;0(11):54-60
23 cases (17 men, 6 women) with acute coronary syndrome (ACS) were investigated at Hue Central Hospital from 2004. There were 14 cases with myocardial infarction (60.87%) and 9 cases with unstable angina (39.13%). The rate of ACS-caused arteries was very high (>92%). Emergency treatment is success in 21/23 patients (91.3%). Good cooperation between related departments (Cardiovascular and Anesthesiology & ICU) is crucial factor for timely emergency intervention in these patients
Acute Coronary Syndrome
;
Myocardial Infarction